Insmed Inc (INSM)

[windyducat]

The market does not like risk and slowly as the trial has unfolded and the risk apparently going down everyday, the market is willing to invest in Insmeds future. $1.80 is still very cheap and the big boys are looking for more than a dime. Conversely, with so much unknowns going into the trial, Insmed could have been severely crippled which is why the price was highly discounted. Soon, Insmed will be able to put the patent infringement behind, even without a 100% victory, and move forward.

Assuming Insmed "wins" at the trial, all the big start up risk are out of the way and management can focus on the business of science and medicine. Raising cash will be much more efficient with this Tericia off our backs!